Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Lee Jackson | Feb 11, 2020 at 7:15 AM EST

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid…

Jon C. Ogg | Feb 10, 2020 at 4:35 PM EST

Moderna Commits to $500 Million Capital Raise, With More Possible

Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the…

Paul Ausick | Feb 10, 2020 at 12:56 PM EST

What the World Health Organization Still Hasn’t Done About Coronavirus

The WHO is convening a meeting Tuesday in Geneva to give researchers and medical practitioners a chance to share information…

Douglas A. McIntyre | Feb 7, 2020 at 1:05 PM EST

When Will Amarin Stock Sell-Off Be Over?

Amarin is a development-stage biotechnology company with one FDA-approved treatment, a cardiovascular disease drug with no real competition. The company…

Chris Lange | Feb 7, 2020 at 11:20 AM EST

Why This Acquisition Could Be Huge for Collegium Pharma

Collegium Pharma shares popped on Friday after the firm announced that it will acquire the U.S. rights to the Nucynta…

Chris Lange | Feb 7, 2020 at 10:20 AM EST

AbbVie Wows Again With Q4 Results

AbbVie released better than expected fourth-quarter financial results before the markets opened on Friday.

Chris Lange | Feb 6, 2020 at 12:50 PM EST

PPD Proves Optimistic in IPO Debut

PPD made an exciting entrance to the market Thursday, pricing its shares at the high end of the expected price…

Chris Lange | Feb 6, 2020 at 10:05 AM EST

Why This First of Its Kind Anaphylaxis Treatment Could Be Huge

Aquestive Therapeutics shares jumped on Thursday after the firm announced that it had a constructive face-to-face meeting with the FDA…

Jon C. Ogg | Feb 5, 2020 at 1:20 PM EST

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin…

Chris Lange | Feb 5, 2020 at 10:05 AM EST

Why This FDA Approval Is a Big Win for Vivus

Vivus shares jumped on Wednesday after the company announced a crucial FDA for its supplemental New Drug Application for an…

Chris Lange | Feb 5, 2020 at 9:55 AM EST

Is Merck Stuck in the Slow Lane?

Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares…

Chris Lange | Feb 4, 2020 at 1:05 PM EST

What to Expect When Merck Reports Before the Opening Bell

Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year…

Chris Lange | Feb 3, 2020 at 11:15 AM EST

Insmed’s Bronchiectasis Study Is a Breath of Fresh Air for Investors

Insmed is one of the few biotechs not tied to the coronavirus that is making a big move to start…

Chris Lange | Feb 3, 2020 at 10:20 AM EST

Is the Coronavirus the Kick-Start Gilead Sciences Stock Needs?

Gilead Sciences shares jumped on Monday after the company announced that it is currently working with China to develop an…

Chris Lange | Feb 3, 2020 at 9:55 AM EST

FDA Approves First-Ever Peanut Allergy Treatment

Aimmune Therapeutics shares jumped early on Monday after the FDA announced late Friday a critical approval for the firm’s peanut…

1 … 69 70 71 72 73 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Moderna Commits to $500 Million Capital Raise, With More Possible

What the World Health Organization Still Hasn’t Done About Coronavirus

When Will Amarin Stock Sell-Off Be Over?

Why This Acquisition Could Be Huge for Collegium Pharma

AbbVie Wows Again With Q4 Results

PPD Proves Optimistic in IPO Debut

Why This First of Its Kind Anaphylaxis Treatment Could Be Huge

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Why This FDA Approval Is a Big Win for Vivus

Is Merck Stuck in the Slow Lane?

What to Expect When Merck Reports Before the Opening Bell

Insmed’s Bronchiectasis Study Is a Breath of Fresh Air for Investors

Is the Coronavirus the Kick-Start Gilead Sciences Stock Needs?

FDA Approves First-Ever Peanut Allergy Treatment

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

5 Big Dividend Pharmaceutical Stocks to Buy as Health Care Could Explode Higher

Moderna Commits to $500 Million Capital Raise, With More Possible

What the World Health Organization Still Hasn’t Done About Coronavirus

When Will Amarin Stock Sell-Off Be Over?

Why This Acquisition Could Be Huge for Collegium Pharma

AbbVie Wows Again With Q4 Results

PPD Proves Optimistic in IPO Debut

Why This First of Its Kind Anaphylaxis Treatment Could Be Huge

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Why This FDA Approval Is a Big Win for Vivus

Is Merck Stuck in the Slow Lane?

What to Expect When Merck Reports Before the Opening Bell

Insmed’s Bronchiectasis Study Is a Breath of Fresh Air for Investors

Is the Coronavirus the Kick-Start Gilead Sciences Stock Needs?

FDA Approves First-Ever Peanut Allergy Treatment

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up